Caputi AP - Search Results

1

Interaction between fluoxetine and haloperidol: pharmacokinetic and clinical implications.

Avenoso A, Spinà E, Campo G, Facciolă G, Ferlito M, Zuccaro P, Perucca E, Caputi AP. Avenoso A, et al. Among authors: caputi ap. Pharmacol Res. 1997 Apr;35(4):335-9. Pharmacol Res. 1997. PMID: 9264051 Clinical Trial.

2

Effect of fluoxetine on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenia.

Spina E, Avenoso A, Facciolà G, Fabrazzo M, Monteleone P, Maj M, Perucca E, Caputi AP. Spina E, et al. Among authors: caputi ap. Int Clin Psychopharmacol. 1998 May;13(3):141-5. doi: 10.1097/00004850-199805000-00009. Int Clin Psychopharmacol. 1998. PMID: 9690983

3

Debrisoquine oxidation in an Italian population: a study in healthy subjects and in schizophrenic patients.

Spina E, Campo GM, Calandra S, Caputi AP, Carrillo JA, Benitez J. Spina E, et al. Among authors: caputi ap. Pharmacol Res. 1992 Jan;25(1):43-50. doi: 10.1016/s1043-6618(05)80063-5. Pharmacol Res. 1992. PMID: 1738757

4

Pharmacogenetic aspects in the metabolism of psychotropic drugs: pharmacokinetic and clinical implications.

Spina E, Caputi AP. Spina E, et al. Among authors: caputi ap. Pharmacol Res. 1994 Feb-Mar;29(2):121-37. doi: 10.1016/1043-6618(94)80036-7. Pharmacol Res. 1994. PMID: 8058586 Review. No abstract available.

5

CYP2D6-related oxidation polymorphism in Italy.

Spina E, Campo GM, Avenoso A, Caputi AP, Zuccaro P, Pacifici R, Gatti G, Strada G, Bartoli A, Perucca E. Spina E, et al. Among authors: caputi ap. Pharmacol Res. 1994 Apr;29(3):281-9. doi: 10.1016/1043-6618(94)80051-0. Pharmacol Res. 1994. PMID: 8058599

6

Endotoxin tolerance impairs a pertussis-toxin-sensitive G-protein regulating tumour necrosis factor release by macrophages from tumour-bearing rats.

Altavilla D, Squadrito F, Canale P, Ioculano M, Campo GM, Squadrito G, Urna G, Sardella A, Caputi AP. Altavilla D, et al. Among authors: caputi ap. Pharmacol Res. 1996 Mar;33(3):203-9. doi: 10.1006/phrs.1996.0028. Pharmacol Res. 1996. PMID: 8880892

7

Relationship between plasma desipramine levels, CYP2D6 phenotype and clinical response to desipramine: a prospective study.

Spina E, Gitto C, Avenoso A, Campo GM, Caputi AP, Perucca E. Spina E, et al. Among authors: caputi ap. Eur J Clin Pharmacol. 1997;51(5):395-8. doi: 10.1007/s002280050220. Eur J Clin Pharmacol. 1997. PMID: 9049581

8

Effect of ketoconazole on the pharmacokinetics of imipramine and desipramine in healthy subjects.

Spina E, Avenoso A, Campo GM, Scordo MG, Caputi AP, Perucca E. Spina E, et al. Among authors: caputi ap. Br J Clin Pharmacol. 1997 Mar;43(3):315-8. doi: 10.1046/j.1365-2125.1997.00539.x. Br J Clin Pharmacol. 1997. PMID: 9088587 Free PMC article. Clinical Trial.

9

Interaction between fluvoxamine and imipramine/desipramine in four patients.

Spina E, Campo GM, Avenoso A, Pollicino MA, Caputi AP. Spina E, et al. Among authors: caputi ap. Ther Drug Monit. 1992 Jun;14(3):194-6. doi: 10.1097/00007691-199206000-00004. Ther Drug Monit. 1992. PMID: 1412604

10

Changes in urinary output after depletion of cerebral acetylcholine stores in the rat.

Trimarchi GR, Campo GM, Caputi AP. Trimarchi GR, et al. Among authors: caputi ap. Pharmacol Res. 1989 Nov-Dec;21 Suppl 1:29-30. doi: 10.1016/s1043-6618(89)80037-4. Pharmacol Res. 1989. PMID: 2633178 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

450 results

Search Page

Filters